/target-data-sheets/epigenetics/brd4(1-2)
6/15/2013 8:50:07 PM
/target-data-sheets/epigenetics/brd4(2)
7/2/2015 2:28:23 AM
/target-data-sheets/epigenetics/brd4(full-length-short-iso-)
6/15/2013 8:50:17 PM
/products/cell-line/sprinter™-k562-brd4-protein-turnover-b-91-1002c042
/products/cell-line/sprinter™-hct-116-brd4-protein-turnove-91-1004c047
An assay platform that robustly and sensitively quantifies the kinetics of endogenous protein turnover is crucial for discovery of disease-relevant therapeutic agents. This need is particularly relevant for a new class of therapeutics known as protein degraders, such as PR...
/tools-resources/document-resource-library/documents/ddc-2020-protein-turnover-poster
8/26/2020 8:28:56 PM
An assay platform that robustly and sensitively quantifies the kinetics of endogenous protein turnover is crucial for discovery of disease-relevant therapeutic agents. This need is particularly relevant for a new class of therapeutics known as protein degraders, such as PR...
/tools-resources/document-resource-library/documents/dot-2020-protein-turnover-poster
9/14/2020 9:13:44 PM
An assay platform that robustly and sensitively quantifies the kinetics of endogenous protein turnover is crucial for discovery of disease-relevant therapeutic agents. This need is particularly relevant for a new class of therapeutics known as protein degraders, such as PRO...
/tools-resources/document-resource-library/documents/keystone-symposium-detection-of-endogenous-prote
6/9/2021 5:58:20 PM
An assay platform that robustly and sensitively quantifies the kinetics of endogenous protein turnover is crucial for discovery of disease-relevant therapeutic agents. This need is particularly relevant for a new class of therapeutics known as protein degraders, such as PROTAC...
/tools-resources/document-resource-library/documents/ddc-2021-sprinter-platform-detection-of-endogen
6/18/2021 10:41:05 PM
An assay platform that robustly and sensitively quantifies the kinetics of endogenous protein turnover is crucial for discovery of disease-relevant therapeutic agents. This need is particularly relevant for a new class of therapeutics known as protein degraders, such as PRO...
/tools-resources/document-resource-library/documents/dot-2021-sprinter-platform-detection-of-endogen
10/14/2021 4:01:08 PM
|<
<
1 2 3
>
>|
Pages: 1 of 3